MétaCan
← all works

Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)

2016· article· en· 1,688 citations· W2763651817 on OpenAlex· 10.1186/s12968-017-0389-8

Why is this work in the frame?

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.

Machine scores (provisional)

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Opus teacher head0.024
GPT teacher head0.285
Teacher spread
0.261 · how far apart the two teachers sit on this one work
Validation status
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Abstract

Parametric mapping techniques provide a non-invasive tool for quantifying tissue alterations in myocardial disease in those eligible for cardiovascular magnetic resonance (CMR). Parametric mapping with CMR now permits the routine spatial visualization and quantification of changes in myocardial composition based on changes in T1, T2, and T2*(star) relaxation times and extracellular volume (ECV). These changes include specific disease pathways related to mainly intracellular disturbances of the cardiomyocyte (e.g., iron overload, or glycosphingolipid accumulation in Anderson-Fabry disease); extracellular disturbances in the myocardial interstitium (e.g., myocardial fibrosis or cardiac amyloidosis from accumulation of collagen or amyloid proteins, respectively); or both (myocardial edema with increased intracellular and/or extracellular water). Parametric mapping promises improvements in patient care through advances in quantitative diagnostics, inter- and intra-patient comparability, and relatedly improvements in treatment. There is a multitude of technical approaches and potential applications. This document provides a summary of the existing evidence for the clinical value of parametric mapping in the heart as of mid 2017, and gives recommendations for practical use in different clinical scenarios for scientists, clinicians, and CMR manufacturers.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

The record

Venue
Journal of Cardiovascular Magnetic Resonance
Topic
Advanced MRI Techniques and Applications
Field
Medicine
Canadian institutions
McGill UniversityUniversity of CalgaryUniversité de MontréalUniversity of AlbertaUniversity of TorontoSickKids FoundationHospital for Sick Children
Funders
Clinical and Translational Science Institute, University of PittsburghNational Institutes of HealthBaker Heart and Diabetes InstituteCentre Hospitalier Universitaire VaudoisUniversité de LausanneUniversité de MontréalHospital for Sick ChildrenUniversity College LondonUniversity of TorontoUniversity of OxfordUniversity of AlbertaRosetrees TrustDeutsches Zentrum für Herz-KreislaufforschungMcGill UniversityKarolinska InstitutetUniversity of Pittsburgh
Keywords
MedicineMagnetic resonance imagingAngiologyMyocardial fibrosisPathologyCardiologyHeart failureRadiology
Has abstract in OpenAlex
yes